3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI

This publication has 32 references indexed in Scilit:

• Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence
  Journal of Neurosurgery, 2002
• Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients
  Journal of Magnetic Resonance Imaging, 2002
• Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy
  International Journal of Radiation Oncology*Biology*Physics, 2002
• Analysis of volume MRI and MR spectroscopic imaging data for the evaluation of patients with brain tumors
  Magnetic Resonance in Medicine, 2001
• MR-spectroscopy guided target delineation for high-grade gliomas
  International Journal of Radiation Oncology*Biology*Physics, 2001
• An automated technique for the quantitative assessment of 3D-MRSI data from patients with glioma
  Journal of Magnetic Resonance Imaging, 2001
• Three-Dimensional Magnetic Resonance Spectroscopic Imaging of Brain and Prostate Cancer
  Neoplasia, 2000
• A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma
  British Journal of Cancer, 1991
• Radiation therapy oncology group (rtog) survival data on anaplastic astrocytomas of the brain: Does a more aggressive form of treatment adversely impact survival?
  International Journal of Radiation Oncology*Biology*Physics, 1989
• Positron Emission Tomography Compared with Magnetic Resonance Imaging and Computed Tomography in Supratentorial Gliomas using Multiple Stereotactic Biopsies as Reference
  Acta Radiologica, 1989